US Phase 2 trial to test targeted drugs in paediatric tumours
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...
List view / Grid view
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...
Scientists discover, a potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer...
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer...
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Polyphor achieves first milestone from Wellcome Trust for the development of antibiotics against Gram-negative multi drug - resistant pathogens...
BenevolentAI announced today it has hired Dr Nathan Brown, as its new Head of Cheminformatics following the promotion of Mark Davies...
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
Researchers have developed a new tools to increase immune response against cancer and infections...
Bacteria or 'superbugs' that have adapted to resist multiple antibiotics are responsible for around 700,000 deaths globally a year; new types of antibiotics are urgently needed...
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.
A team of researchers – headed by the University of Zurich – have discovered a new mechanism by which bacteria are protected from invading viruses and molecular parasites.
The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.
A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.
The study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumour immunity...